Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough
Teva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough
Teva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough
Submitted by
admin
on August 6, 2014 - 8:14am
Source:
Fierce Pharma Marketing
News Tags:
Teva Pharmaceutical
MS
multiple sclerosis
Copaxone
Headline:
Teva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough
Do Not Allow Advertisers to Use My Personal information
